Free Trial

Novavax (NVAX) Short Interest Ratio & Short Volume

Novavax logo
$9.55 +0.05 (+0.53%)
Closing price 10/2/2025 04:00 PM Eastern
Extended Trading
$9.52 -0.03 (-0.31%)
As of 05:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novavax Short Interest Data

Novavax (NVAX) has a short interest of 44.72 million shares. This marks a 1.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.1, indicating that it would take 7.1 days of the average trading volume of 4.64 million shares to cover all short positions.

Current Short Interest
44,720,000 shares
Previous Short Interest
43,870,000 shares
Change Vs. Previous Month
+1.94%
Dollar Volume Sold Short
$361.34 million
Short Interest Ratio
7.1 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
162,422,000 shares
Percentage of Shares Shorted
27.53%
Today's Trading Volume
4,326,853 shares
Average Trading Volume
4,637,668 shares
Today's Volume Vs. Average
93%
Short Selling Novavax?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Novavax and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

NVAX Short Interest Over Time

NVAX Days to Cover Over Time

NVAX Percentage of Float Shorted Over Time

Novavax Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202544,720,000 shares $361.34 million +1.9%N/A7.1 $8.08
8/31/202543,870,000 shares $327.71 million +15.1%27.3%6.9 $7.47
8/15/202538,100,000 shares $365.00 million -10.0%N/A5.8 $9.58
7/31/202542,310,000 shares $281.36 million -1.8%26.3%4.9 $6.65
7/15/202543,080,000 shares $296.39 million -7.5%N/A5.2 $6.88
6/30/202546,560,000 shares $293.33 million +4.7%29.0%5.4 $6.30
6/15/202544,480,000 shares $308.69 million -0.5%27.7%5.1 $6.94
5/31/202544,700,000 shares $330.33 million -3.8%28.2%5.3 $7.39
5/15/202546,470,000 shares $292.30 million +9.8%29.3%5.7 $6.29
4/30/202542,330,000 shares $282.34 million +3.2%N/A7 $6.67
4/15/202541,030,000 shares $262.18 million +11.3%25.9%8.1 $6.39
3/31/202536,880,000 shares $236.40 million -1.8%23.3%7.9 $6.41
3/15/202537,550,000 shares $300.02 million -4.3%23.7%8.9 $7.99
2/28/202539,230,000 shares $326.79 million +10.7%24.7%9.2 $8.33
2/15/202535,450,000 shares $290.34 million +1.5%22.4%8.8 $8.19
1/31/202534,940,000 shares $303.63 million -8.2%N/A7.8 $8.69
1/15/202538,070,000 shares $325.50 million +3.1%N/A8.2 $8.55
12/31/202436,920,000 shares $296.84 million -5.7%N/A7 $8.04
12/15/202439,160,000 shares $356.75 million -1.6%N/A7 $9.11
11/30/202439,780,000 shares $346.88 million -4.2%N/A6.6 $8.72
11/15/202441,510,000 shares $303.85 million +3.8%N/A6.5 $7.32
10/31/202439,980,000 shares $384.21 million +11.9%N/A6.6 $9.61
10/15/202435,720,000 shares $450.07 million +5.4%N/A5.3 $12.60
9/30/202433,880,000 shares $427.90 million +1.0%N/A5 $12.63
9/15/202433,530,000 shares $456.34 million +6.1%N/A5 $13.61
8/31/202431,610,000 shares $391.33 million +3.6%N/A4.1 $12.38
8/15/202430,500,000 shares $385.52 million +6.1%N/A2.9 $12.64
7/31/202428,760,000 shares $368.42 million -8.4%N/A1.7 $12.81
7/15/202431,400,000 shares $474.77 million +6.3%N/A1.9 $15.12
6/30/202429,530,000 shares $373.85 million -25.6%N/A1.9 $12.66
6/15/202439,710,000 shares $571.82 million +3.9%N/A2.6 $14.40
5/31/202438,210,000 shares $574.30 million -15.6%N/A2.7 $15.03
5/15/202445,290,000 shares $584.24 million +0.8%N/A3.5 $12.90
4/30/202444,930,000 shares $194.55 million +2.7%N/A6.6 $4.33
4/15/202443,770,000 shares $180.33 million -0.3%N/A6.1 $4.12
3/31/202443,910,000 shares $209.89 million -8.8%N/A5.5 $4.78
3/15/202448,130,000 shares $254.61 million -8.7%N/A5.6 $5.29
2/29/202452,740,000 shares $260.54 million -3.8%N/A5.5 $4.94
2/15/202454,830,000 shares $235.77 million +5.3%N/A6.4 $4.30
1/31/202452,090,000 shares $208.36 million +2.3%N/A6.9 $4.00
1/15/202450,910,000 shares $233.17 million +3.5%N/A7 $4.58
12/31/202349,200,000 shares $236.16 million +8.0%N/A6.5 $4.80
12/15/202345,540,000 shares $245.92 million +5.6%N/A6 $5.40
11/30/202343,110,000 shares $237.11 million +4.8%N/A5.6 $5.50
11/15/202341,150,000 shares $255.13 million -8.4%N/A4.7 $6.20
10/31/202344,910,000 shares $299.10 million +4.5%N/A4.7 $6.66
10/15/202342,990,000 shares $303.08 million -3.3%N/A4.3 $7.05
9/30/202344,440,000 shares $321.75 million -0.1%N/A4.7 $7.24
9/15/202344,500,000 shares $343.10 million +11.0%N/A5 $7.71
8/31/202340,090,000 shares $320.72 million +0.7%N/A4.7 $8.00
8/15/202339,800,000 shares $288.15 million +7.7%N/A5.6 $7.24
7/31/202336,950,000 shares $342.90 million +0.7%N/A5.5 $9.28
7/15/202336,690,000 shares $318.47 million +0.7%N/A6.1 $8.68
6/30/202336,450,000 shares $270.82 million +18.2%N/A5.8 $7.43
6/15/202330,840,000 shares $248.57 million +2.7%N/A5.3 $8.06
5/31/202330,030,000 shares $241.74 million -6.0%N/A5.2 $8.05
5/15/202331,930,000 shares $258.95 million -5.0%N/A5 $8.11
4/30/202333,600,000 shares $257.71 million -1.6%N/A5.4 $7.67
4/15/202334,150,000 shares $312.81 million -9.6%N/A5.5 $9.16
3/31/202337,770,000 shares $261.75 million +13.6%N/A5.9 $6.93
3/15/202333,240,000 shares $196.12 million -2.6%N/A5 $5.90
2/28/202334,110,000 shares $315.86 million +6.4%N/A4.6 $9.26
2/15/202332,050,000 shares $326.59 million +3.9%N/A4.7 $10.19
1/31/202330,840,000 shares $336.46 million -0.2%N/A4.5 $10.91
1/15/202330,910,000 shares $379.88 million +1.6%N/A4.7 $12.29
12/30/202230,410,000 shares $312.61 million +24.3%N/A4.5 $10.28
12/15/202224,470,000 shares $277.00 million +3.8%N/A3.9 $11.32
11/30/202223,570,000 shares $388.67 million +4.4%N/A4.7 $16.49
11/15/202222,580,000 shares $524.31 million +0.6%N/A4.7 $23.22
10/31/202222,450,000 shares $499.96 million +5.1%N/A4.5 $22.27
10/15/202221,360,000 shares $420.15 million +9.5%N/A4 $19.67
9/30/202219,500,000 shares $354.90 million +14.6%N/A3.2 $18.20
9/15/202217,020,000 shares $554.00 million +9.0%N/A2.8 $32.55
8/31/202215,620,000 shares $516.08 million +0.8%N/A2.4 $33.04
8/15/202215,490,000 shares $655.23 million -5.1%N/A2.1 $42.30
7/31/202216,330,000 shares $890.15 million +8.9%N/A2.2 $54.51
7/15/202214,990,000 shares $815.91 million +1.4%N/A2.1 $54.43
6/30/202214,780,000 shares $760.14 million -6.0%N/A2.3 $51.43
6/15/202215,730,000 shares $648.55 million +30.0%N/A2.7 $41.23
5/31/202212,100,000 shares $669.49 million -15.3%N/A2.2 $55.33
5/15/202214,290,000 shares $741.51 million +17.4%N/A3.1 $51.89
4/30/202212,170,000 shares $548.50 million +0.4%N/A2.7 $45.07
4/15/202212,120,000 shares $709.63 million +11.3%N/A2.6 $58.55
3/31/202210,890,000 shares $802.05 million +7.6%N/A2.2 $73.65
3/15/202210,120,000 shares $746.86 million +5.0%N/A1.8 $73.80
2/28/20229,640,000 shares $803.69 million +1.8%N/A1.6 $83.37
2/15/20229,470,000 shares $825.12 million +2.7%N/A1.5 $87.13
1/31/20229,220,000 shares $863.91 million -4.0%N/A1.5 $93.70
1/15/20229,600,000 shares $1.06 billion +7.5%N/A1.6 $110.82
12/31/20218,930,000 shares $1.28 billion +6.7%N/A1.5 $143.07
12/15/20218,370,000 shares $1.50 billion +8.1%N/A1.5 $179.49
11/30/20217,740,000 shares $1.61 billion -10.1%N/A1.5 $208.63
11/15/20218,610,000 shares $1.48 billion +4.5%N/A1.8 $172.45
10/29/20218,240,000 shares $1.23 billion +33.8%11.2%1.5 $148.83
10/15/20216,160,000 shares $997.61 million +1.5%8.4%1.1 $161.95
9/30/20216,070,000 shares $1.26 billion -9.1%8.2%1.2 $207.31
9/15/20216,680,000 shares $1.55 billion +9.9%9.1%1.4 $232.30
8/31/20216,080,000 shares $1.45 billion -15.3%8.3%1.2 $238.54
8/13/20217,180,000 shares $1.85 billion +21.9%9.8%1.4 $257.27
7/30/20215,890,000 shares $1.06 billion -2.6%8.0%1.3 $179.33
7/15/20216,050,000 shares $1.08 billion -0.5%8.2%1.4 $179.14
6/30/20216,080,000 shares $1.29 billion +5.0%8.3%1.5 $212.31
6/15/20215,790,000 shares $1.08 billion -0.3%7.9%1.5 $187.07
5/28/20215,810,000 shares $857.67 million +10.9%7.9%1.7 $147.62
5/14/20215,240,000 shares $634.04 million +17.8%N/A1.5 $121.00
4/30/20214,450,000 shares $1.06 billion -5.3%N/A1.2 $237.53
4/15/20214,700,000 shares $946.30 million +9.6%N/A1.1 $201.34
3/31/20214,290,000 shares $743.54 million -13.3%N/A1 $173.32
3/15/20214,950,000 shares $1.00 billion -7.1%N/A1.1 $202.77
2/26/20215,330,000 shares $1.18 billion -13.1%N/A1.2 $221.50
2/12/20216,130,000 shares $1.83 billion -1.1%N/A1.2 $298.26
1/29/20216,200,000 shares $830.86 million -11.1%N/A1.2 $134.01
1/15/20216,970,000 shares $905.96 million -4.9%N/A1.7 $129.98
12/31/20207,330,000 shares $871.98 million +1.4%N/A1.8 $118.96
12/15/20207,230,000 shares $937.73 million -19.4%N/A1.8 $129.70
11/30/20208,970,000 shares $1.13 billion +3.0%N/A2.1 $125.69
11/15/20208,710,000 shares $841.39 million +8.9%N/A2 $96.60
10/30/20208,000,000 shares $701.04 million +7.7%N/A1.6 $87.63
10/15/20207,430,000 shares $830.38 million -5.0%N/A1.3 $111.76

NVAX Short Interest - Frequently Asked Questions

What is Novavax's current short interest?

Short interest is the volume of Novavax shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 44,720,000 shares of NVAX short. Learn More on Novavax's current short interest.

What is a good short interest ratio for Novavax?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVAX shares currently have a short interest ratio of 7.0. Learn More on Novavax's short interest ratio.

Which institutional investors are shorting Novavax?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novavax: Nomura Holdings Inc., Sculptor Capital LP, Group One Trading LLC, Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Caption Management LLC, Walleye Capital LLC, Walleye Trading LLC, Capital Fund Management S.A., JPMorgan Chase & Co., Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Novavax's short interest increasing or decreasing?

Novavax saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 44,720,000 shares, an increase of 1.9% from the previous total of 43,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Novavax's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Novavax: Moderna, Inc. (18.43%), Ocugen, Inc. (18.50%), Vaxart, Inc. (3.01%), Johnson & Johnson (0.91%), Pfizer Inc. (1.99%), Alkermes plc (9.12%), Ligand Pharmaceuticals Incorporated (5.72%), Amicus Therapeutics, Inc. (6.79%), Celldex Therapeutics, Inc. (9.91%), MannKind Corporation (5.61%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Novavax stock?

Short selling NVAX is an investing strategy that aims to generate trading profit from Novavax as its price is falling. NVAX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Novavax?

A short squeeze for Novavax occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVAX, which in turn drives the price of the stock up even further.

How often is Novavax's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVAX, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:NVAX) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners